Drug intelligence / Profile preview

atenolol + chlorthalidone (Almirall)

Development stage
Phase 3
Lead developer
AkzoNobel
Modality
Small Molecules
Administration
Oral
01

Overview

Blokium DIU is a fixed-dose combination antihypertensive medication containing the cardioselective beta-1 adrenergic receptor antagonist atenolol and the long-acting monosulfonamyl (thiazide-like) diuretic chlorthalidone. Atenolol reduces blood pressure by decreasing heart rate, myocardial contractility, and cardiac output, while chlorthalidone promotes the renal excretion of sodium, chloride, and water by inhibiting the sodium-chloride symporter in the distal convoluted tubule. This dual mechanism of action provides synergistic blood pressure reduction and is indicated for the management of essential hypertension, particularly in patients whose blood pressure is not adequately controlled by monotherapy.

Brand names
Blokium DIUBlokium-DiuTenoretTenoretic
Other names
atenolol and chlorthalidoneatenolol/chlorthalidoneco-tenidone
02

Targets

ADRB1 (β1)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on atenolol + chlorthalidone (Almirall).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atenolol + chlorthalidone (Almirall).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call